Anti-Proprotein Convertase Subtilisin Kexin Type 9 (Anti-PCSK9) Compounds and Methods of Using the Same in the Treatment and/or Prevention of Cardiovascular Diseases
- 专利权人:
- Shifa Biomedical Corporation
- 发明人:
- Sherin Salaheldin Abdel-Meguid,Nabil A. Elshourbagy,Harold V. Meyers,Shaker A. Mousa
- 申请号：
- US16308648
- 公开号：
- US20190270729A1
- 申请日:
- 2017.06.19
- 申请国别(地区):
- US
- 年份:
- 2019
- 代理人:
- 摘要：
- Disclosed are compounds that modulate the physiological action of the proprotein convertase subtilisin kexin type 9 (PCSK9), as well as therapeutic methods for use of such compounds to reduce LDL-cholesterol levels and/or for the treatment and/or prevention of cardiovascular disease (CVD), including treatment of hypercholesterolemia.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Anti-Proprotein Convertase Subtilisin Kexin Type 9 (Anti-PCSK9) Compounds and Methods of Using the Same in the Treatment and/or Prevention of Cardiovascular Diseases
- ANTI-PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (ANTI-PCSK9) COMPOUNDS AND METHODS OF USING THE SAME IN THE TREATEMNT AND/OR PREVENTION OF CARDIOVASCULAR DISEASES
- ANTI-PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (ANTI-PCSK9) COMPOUNDS AND METHODS OF USING THE SAME IN THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR DISEASES
- ANTI-PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (ANTI-PCSK9) COMPOUNDS AND METHODS OF USING THE SAME IN THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR DISEASES
- Anti-proprotein convertase subtilisin / kexin type 9 (anti-PCSK9) compounds and methods for their use in the treatment and / or prevention of cardiovascular disease
